Registration - Consultant

Alexion Pharma Canada Corp. / WILLIAM DEMPSTER, Consultant

Registration Information

Client name: Alexion Pharma Canada Corp.
Lobbyist name: WILLIAM DEMPSTER, Consultant
Initial registration start date: 2022-09-28
Registration status: Active
Registration Number: 778465-372825

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 1 (2022-09-28 to present)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Intellectual Property
Internal Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda and other government policies and programs related to incentivizing research and development activities in Canada, including the Biomanufacturing and Life Sciences Strategy.
Policies related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
The federal role in considering developing and/or funding a national pharmacare program, including engagement with the Advisory Council on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disease and orphan drug policies, including the evolving Drugs for Rare Diseases Strategy.

Policies or Program, Regulation

Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
3100 Rutherford Road Suite 300
Vaughan, ON L4K 0G6
Canada

Telephone number: 866-393-1188
Web address: https://alexion.com/worldwide/canada

Client representative

Kathleen Whelan, Country Lead, International Government Affairs & Policy

Parent Company Information

AstraZeneca / AstraZeneca
- 1004 Middlegate Road, Suite 5000
  Mississauga, ON L4Y 1M4
  Canada

Coalition Members Information

Alexion Pharma Canada Corp. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Alexion Pharma Canada Corp. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Alexion Pharma Canada Corp. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

WILLIAM DEMPSTER | Public offices held

Business address:
150 Metcalfe Street
Suite 604
OTTAWA, ON K2P 1P1
Canada

Telephone number: 613-614-0283
Fax number: 613-249-3645

Consultant Firm and Address

Firm: 3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.

Address:
150 Metcalfe Street
Suite 604
Ottawa, ON K2P 1P1
Canada

Telephone number: 613-800-8340
Fax number: 613-800-8343

Alexion Pharma Canada Corp./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Alexion Pharma Canada Corp./	2022-09-28	current

Alexion Pharma Canada Corp.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Assistant House of Commons, Office of the Hon. Irwin Cotler, MP	2002 to 2003	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Assistant House of Commons, Office of the Hon. Irwin Cotler, MP	2002 to 2003	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Alexion Pharma Canada Corp. / WILLIAM DEMPSTER, Consultant

Registration Information

Associated Communications

Version 1 of 1 (2022-09-28 to present)

Version 1 of 1 (2022-09-28 to present)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Registration - Consultant

Alexion Pharma Canada Corp. / WILLIAM DEMPSTER, Consultant

Version 1 of 1 (2022-09-28 to present)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Alexion Pharma Canada Corp./

The following names have been used on or after July 2, 2008

Alexion Pharma Canada Corp.

WILLIAM DEMPSTER, 3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc. (Consultant)